exercise intervention delivered via the internet at different cancer centers in New England.
The investigators hypothesize that participants will lose 7% of their body weight. The
research is being done because many women who are treated for breast cancer are overweight
and treatment for breast cancer is often accompanied by weight gain. Individuals who are
overweight may be more likely to have their breast cancer come back. Also women who
exercise at least three hours a week seem to have less chance of their cancer coming back.
The investigators hope to identify an effective weight loss and exercise intervention for
breast cancer survivors that can be easily accessed by many people.
This study is designed to determine the feasibility of conducting a distantly
delivered-weight loss and exercise intervention for patients who have been treated for
breast cancer at three cancer centers, and to evaluate the efficacy of an Internet-based
behavioral weight loss and exercise intervention delivered to overweight/obese breast cancer
survivors in three New England locations.
Participants will be recruited from three New England Cancer Centers - the Vermont Cancer
Center, Norris Cotton Cancer Center at Dartmouth University and the University of
Massachusetts Cancer Center. Participants from each center will undergo baseline
assessments that include diet assessment, body measurements (height, weight, etc), a
physical activity assessment and be asked to complete a series of questionnaires.
Patients that meet the minimum requirements will be enrolled on the study. They will
participate in weekly on-line "chats" about behavioral and diet modifications led by a
qualified facilitator. Participants will also engage in increasing amounts of aerobic
activity (typically walking) throughout the course of the intervention. The intervention
lasts 6 months. At the end of those 6 months, participants will have the same assessments
that were collected at baseline. Following the collection of those assessments,
participants will have completed the study.
For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:
- Cancer Help Line: (800) 639-6918
- Email: email@example.com
Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.